GlassScriptPhysician profile
Jeong W Choi
NPI 1497918213
$1,851.29
in general payments reported to CMS, 2019-2025
10 companies · $234 in 2025
The $234 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $18.89 · 2022: $281 · 2023: $27.32 · 2024: $962 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732 · Travel and Lodging: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.19 |
| Travel and Lodging | $491.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $631.46 | 2024 | (Bs3) Intracardiac Und, (Ao0) Igt Devices Intracardiac |
| Edwards Lifesciences Corporation | $284.79 | 2022-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $253.63 | 2019-2025 | Watchman Flx |
| Abbott Laboratories | $215.09 | 2024 | Mitraclip |
| Siemens Medical Solutions USA, INC. | $152.76 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.65 | 2019 | |
| Abiomed | $87.87 | 2019 | |
| Medtronic, INC. | $61.60 | 2025 | Corevalve Evolut R |
| Pfizer INC. | $41.12 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $27.32 | 2023 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeong Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.